<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02290067</url>
  </required_header>
  <id_info>
    <org_study_id>OPM-G-V-1203</org_study_id>
    <secondary_id>IDT-1340-BE</secondary_id>
    <nct_id>NCT02290067</nct_id>
  </id_info>
  <brief_title>System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus</brief_title>
  <official_title>EVALUATING SYSTEM ACCURACY AND USER PERFORMANCE OF BLOOD GLUCOSE MONITORING SYSTEMS FOR SELF-TESTING IN MANAGING DIABETES MELLITUS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>B. Braun Melsungen AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this test is to determine the system accuracy and user performance evaluation of
      three Blood Glucose Monitoring systems. For system accuracy evaluation the measurement data
      should cover the whole range of glucose concentration which could usually be expected in
      patients with diabetes mellitus.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>System accuracy, results obtained from fingertip using blood glucose monitoring systems compared to a reference equipment</measure>
    <time_frame>up to 6 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>User performance of blood glucose monitoring systems indicated by patient [questionnaire]</measure>
    <time_frame>up to 4 hours</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Omnitest 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Blood glucose monitoring system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omnitest 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood glucose monitoring system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omnitest 5D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood glucose monitoring system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood glucose monitoring system (Omnitest 3)</intervention_name>
    <arm_group_label>Omnitest 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood glucose monitoring system (Omnitest 5)</intervention_name>
    <arm_group_label>Omnitest 5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood glucose monitoring system (Omnitest 5D)</intervention_name>
    <arm_group_label>Omnitest 5D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with type 1 or type 2 diabetes and healthy subjects

          -  Signed and dated informed consent form

          -  For small modifications of the insulin doses to achieve certain blood glucose values
             (system accuracy evaluation): Male or female subjects with diabetes mellitus type 1
             with intensified insulin therapy (intensified conventional therapy) or insulin pump
             therapy (continuous subcutaneous insulin infusion)

        Exclusion Criteria:

          -  Pregnancy or lactation period

          -  Severe acute illness that in the opinion of the investigating physician might confound
             the results of the test or which could result in a risk to the patient caused by the
             test

          -  Mental incapacity or language barriers precluding adequate compliance with the test
             procedures

          -  Severe chronic illness besides diabetes mellitus as assessed by the investigating
             physician that might confound the results of the test or which could result in a risk
             to the patient caused by the test

          -  Legal incompetence or limited legal competence

          -  Dependency from the sponsor or the clinical investigator (e.g. coworkers of the
             sponsor or the clinical research center)

          -  For user performance evaluation: Subjects having used the test systems before
             themselves or having participated in a study with these Blood Glucose Monitoring
             Systems

          -  For system accuracy evaluation: subjects intended to provide blood samples with
             glucose concentrations between 50 and 80 mg/dl must not have coronary heart disease,
             myocardial infarction in history, cerebral events in history, peripheral artery
             occlusive disease- or impaired hypoglycaemia awareness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nina Jendrike, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft</name>
      <address>
        <city>ULM</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2014</study_first_submitted>
  <study_first_submitted_qc>November 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2014</study_first_posted>
  <last_update_submitted>December 19, 2014</last_update_submitted>
  <last_update_submitted_qc>December 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>blood glucose monitoring system</keyword>
  <keyword>system accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

